Souders Financial Advisors Has $3.52 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Souders Financial Advisors trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 28.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,713 shares of the healthcare conglomerate's stock after selling 2,699 shares during the quarter. Souders Financial Advisors' holdings in UnitedHealth Group were worth $3,516,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Norges Bank acquired a new stake in UnitedHealth Group during the fourth quarter valued at $6,375,744,000. GAMMA Investing LLC boosted its position in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares during the last quarter. Northern Trust Corp increased its position in UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after buying an additional 1,058,488 shares during the last quarter. Finally, Capital International Investors increased its position in UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after buying an additional 906,365 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the business's stock in a transaction on Friday, May 16th. The stock was purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer owned 679,493 shares of the company's stock, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on UNH. Deutsche Bank Aktiengesellschaft cut their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Truist Financial dropped their price objective on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research note on Wednesday, July 16th. Wolfe Research reduced their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Robert W. Baird lowered UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price for the company. in a research note on Wednesday, June 11th. Finally, KeyCorp lowered their target price on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a research note on Monday, June 2nd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $394.43.

UnitedHealth Group Trading Up 1.2%

NYSE:UNH traded up $3.44 on Tuesday, reaching $285.58. The company's stock had a trading volume of 11,531,603 shares, compared to its average volume of 7,845,145. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market cap of $259.06 billion, a PE ratio of 11.94, a PEG ratio of 1.38 and a beta of 0.45. The business's 50-day moving average price is $304.47 and its two-hundred day moving average price is $432.39.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 3.10%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.